BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, December 28, 2025
Home » Authors » Sharon Kingman

Articles by Sharon Kingman

Gene for Melanoma Cell Survival Could Be New Therapeutic Target

July 11, 2012
By Sharon Kingman
LONDON – A molecule that is needed for the proliferation and survival of malignant melanoma cells could hold clues to new therapies to treat that aggressive skin cancer.
Read More

Boosting a Single Protein in Brain Helps Mice Remember

July 6, 2012
By Sharon Kingman
LONDON – Decreasing levels of a protein in the brain are linked to a reduced ability to form long-term memories in aging animals, a study in mice suggested.
Read More

Boosting a Single Protein in Brain Helps Mice Remember

July 5, 2012
By Sharon Kingman
LONDON – Decreasing levels of a protein in the brain are linked to a reduced ability to form long-term memories in aging animals, a study in mice suggested.
Read More

Study Shows New Facet of Telomerase Regulation

June 27, 2012
By Sharon Kingman
LONDON – A newly identified link between a crucial developmental signaling pathway and regulation of the enzyme telomerase could one day lead to new therapies to treat cancer and degenerative diseases.
Read More

Scientists Probe Dopamine's Role in Sleep-Wake Cycle

June 20, 2012
By Sharon Kingman
LONDON – The neurotransmitter dopamine has a direct influence on the production and release of the hormone melatonin, which helps to regulate the body's circadian rhythm, researchers have found.
Read More

Structure of Bacterial Armor Revealed in Imaging Study

June 13, 2012
By Sharon Kingman
LONDON – A first glimpse of the outer protein coat present on many bacteria, including some important pathogens, has revealed that it is a highly regular, tight-knit structure, which researchers have likened to medieval chain mail.
Read More

Molecular Switch Could Be Target for New HCV Drugs

June 6, 2012
By Sharon Kingman
LONDON – The discovery that hepatitis C viruses (HCVs) probably use the same molecular switch to control their replication could lead to new treatments for that infection.
Read More

Diabetes Drug Metformin Offers Insight into Cancer Treatments

May 30, 2012
By Sharon Kingman
LONDON – An Italian team has unravelled the mechanism by which metformin, a common diabetes drug, helps to reduce the incidence of cancer in those who take it.
Read More

Mutations Reveal Evolution of Breast Cancer Genome

May 23, 2012
By Sharon Kingman
LONDON – Whole-genome analysis of 21 individual breast cancers has yielded a glimpse of the enormous number, type and extent of mutations present in breast tumors.
Read More

Vitamin K2 Provides Clue to Cause of Parkinson's Disease

May 16, 2012
By Sharon Kingman
LONDON – It may be possible to correct a defect in mitochondria that occurs in many cases of Parkinson's disease with the help of a humble vitamin, researchers in Belgium have discovered.
Read More
Previous 1 2 … 11 12 13 14 15 16 17 18 19 … 107 108 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 24, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 24, 2025.
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • Businessman, businesswoman handshake

    Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact

    BioWorld
    Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
  • Illustration of tau accumulating in a neuron cell.

    ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug

    BioWorld
    ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing